SMMT
Summit Therapeutics Inc
Price:  
17.55 
USD
Volume:  
4,271,188.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SMMT Stock Forecast & Price Target

SMMT Stock Price Forecast

The average stock forecast for Summit Therapeutics Inc (SMMT) in the next 12 months is 28.47 USD. This price target corresponds to an upside of 66.22%. The range of stock forecasts for SMMT is 11.11 - 43.05 USD. Based on the ratings of 24 analysts, the consensus recommendation for SMMT is BUY.
Target Low Average Median High
Price (USD) 11.11 28.47 31.62 43.05
Upside -35.14% 66.22% 84.59% 151.31%

Recommendation Trends

The latest consensus rating for SMMT is "BUY". This is the average recommendation of 24 analysts: 0 strong sell, 0 sell, 8 hold, 11 buy, 5 strong buy. In the previous period, 24 analysts also majorly recommmended "BUY" for SMMT.

SMMT Financial Stock Forecast

Revenue This Year
3.98M
from -M
Revenue Next Year
60.36M
1,417.37%
from 3.98M
EPS This Year
-1.21
from -
EPS Next Year
-1.17
-3.16%
from -1.21